Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life : a Campus CML study / G. Caocci, O. Mulas, I. Capodanno, E. Abruzzese, A. Iurlo, L. Luciano, F. Albano, M. Annunziata, M. Tiribelli, M. Bonifacio, S. Galimberti, F. Castagnetti, N. Sgherza, F. Stagno, A. Gozzini, E.M. Orlandi, D. Luzi, G. Binotto, P. Pregno, C. Fozza, F. Efficace, M.P. Simula, M.M. Trawinska, D. Cattaneo, F. De Gregorio, I. Attolico, R. Stella, L. Scaffidi, C. Barate, G. Gugliotta, E. Scalzulli, C. Elena, F. Pirillo, R. Foa, M. Breccia, G.L. Nasa. - In: BLOOD CANCER JOURNAL. - ISSN 2044-5385. - 10:6(2020 Jun 08), pp. 66.1-66.6. [10.1038/s41408-020-0333-2]
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life : a Campus CML study
D. Cattaneo;
2020
File | Dimensione | Formato | |
---|---|---|---|
Caocci G et al. Blood Cancer J 2020.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
655.51 kB
Formato
Adobe PDF
|
655.51 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.